Diphenylpyraline (INN) and its salts
Diphenylpyraline (INN) and its salts is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

Diphenylpyraline
Diphenylpyraline is a member of the class of piperidines that is the benzhydryl ether derivative of 1-methyl-4-hydroxypiperidine. A sedating antihistamine, it is used as the hydrochloride for the symptomatic relief of allergic conditions including rhinitis and hay fever, and in pruritic skin disorders. It is also used as the teoclate salt (piprinhydrinate) as an ingredient in compound preparations for the symptomatic relief of coughs and the common cold. It has a role as a H1-receptor antagonist and a cholinergic antagonist. It is a member of piperidines and a tertiary amine. — ChEBI
- IUPAC name
- 4-benzhydryloxy-1-methylpiperidine
- Molecular formula
- C19H23NO
- Molecular weight
- 281.4 g/mol
- Exact mass
- 281.177964357 Da
- XLogP3
- 3.9
- Topological polar surface area
- 12.5 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:59788
- ChEMBL:CHEMBL1492
- EPA DTXSID:DTXSID3022952
- PubMed:22445882
- PubMed:22364032
- PubMed:22291486
- PubMed:21818443
- PubMed:19574011
- PubMed:19472275
- PubMed:19231896
- PubMed:18977145
- PubMed:18273383
- PubMed:17714832
- PubMed:16419026
- PubMed:15627433
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Diphenylpyraline (INN) and its salts
Regulatory information
Key data
Related records for Diphenylpyraline (INN) and its salts
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Dimevamide (INN) and its salts
N-(3-Carbamoyl-3,3-diphenylpropyl)-N,N-diisopropylmethylammonium salts, e.g. isopropamide iodide (I…
Dinitrophenol isomers
Cyclizine (INN) and its salts
5,5-Diphenyl-4-imidazolidone (Doxenitoin (INN))
What Annex II means for Diphenylpyraline (INN) and its salts
Diphenylpyraline (INN) and its salts is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Diphenylpyraline (INN) and its salts
This page summarizes one Annex II record for Diphenylpyraline (INN) and its salts from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Diphenylpyraline (INN) and its salts, but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Diphenylpyraline (INN) and its salts and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Diphenylpyraline (INN) and its salts side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II